Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson’s and Alzheimer’s diseases-Reference-Cited by-同舟云学术

Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson’s and Alzheimer’s diseases

Published:2013-07 Issue: Volume:242 Page:140-150
ISSN:0306-4522
Container-title:Neuroscience
language:en
Short-container-title:Neuroscience

Author:

Hannula M.J.,Myöhänen T.T.,Tenorio-Laranga J.,Männistö P.T.,Garcia-Horsman J.A.

Publisher

Elsevier BV

Subject

General Neuroscience

Reference66 articles.

1. Ontogeny of prolyl endopeptidase and pyroglutamyl peptidase I in rat tissues;Agirregoitia;Regul Pept,2007

2. Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin: a rebuttal;Agusti-Cobos;J Thromb Haemost,2011

3. Expression and processing of pathologic proteins in Alzheimer’s disease;Anderton;Hippocampus,1993

4. Deficiency of kallikrein-like enzyme activities in cerebral tissue of patients with Alzheimer’s disease;Aoyagi;Experientia,1990

5. Localization of the mRNA encoding prolyl endopeptidase in the rat brain and pituitary;Bellemere;J Comp Neurol,2004

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activity-based NIR specific fluorescent probe reveals the abnormal elevation of prolyl endopeptidase in hippocampus during Alzheimer's disease progression;Sensors and Actuators B: Chemical;2024-10

2. Effect of chiral silver nanoparticles on prolyl-oligopeptidase binding and activity;Frontiers in Nanotechnology;2024-07-29

3. The active components of Erzhi wan and their anti-Alzheimer's disease mechanisms determined by an integrative approach of network pharmacology, bioinformatics, molecular docking, and molecular dynamics simulation;Heliyon;2024-07

4. Exploring bi-carbazole-linked triazoles as inhibitors of prolyl endo peptidase via integrated in vitro and in silico study;Scientific Reports;2024-04-01

5. Bioinformatic analysis of the SPs and NFTs proteomes unravel putative biomarker candidates for Alzheimer's disease;PROTEOMICS;2023-05